Ludwig-Maximilians-Universität (LMU)

University / College


Location: München, Germany (DE) DE

ISNI: 000000041936973X

ROR: https://ror.org/05591te55

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

How a surgeon becomes superman by visualization of intelligently fused multi-modalities (2013) Erat O, Pauly O, Weidert S, Thaller P, Euler E, Mutschler W, Navab N, Fallavollita P Conference contribution Development and procedural evaluation of immersive medical simulation environments (2013) Wucherer P, Stefan P, Weidert S, Fallavollita P, Navab N Conference contribution Learning from multiple experts with random forests: Application to the segmentation of the midbrain in 3D ultrasound (2013) Chatelain P, Pauly O, Peter L, Ahmadi SA, Plate A, Bötzel K, Navab N Conference contribution Kinect for interactive AR anatomy learning (2013) Meng M, Fallavollita P, Blum T, Eck U, Sandor C, Weidert S, Waschke J, Navab N Conference contribution Atherosclerotic plaque burden in cocaine users with acute chest pain: Analysis by coronary computed tomography angiography (2013) Ebersberger U, Sudarski S, Schoepf UJ, Bamberg F, Tricarico F, Apfaltrer P, Blanke P, et al. Journal article Recommendations of the project group prevention of the German Cardiac Society (DGK) on risk adjusted prevention of cardiovascular diseases: Part 3: Dyslipidemia, arterial hypertension and glucose metabolism Empfehlungen der Projektgruppe Prävention der DGK zur risikoadjustierten Prävention von Herz- und Kreislauferkrankungen: Teil 3: Fettstoffwechselstörungen, arterielle Hypertonie und Glukosestoffwechsel (2013) Gohlke H, Albus C, Bönner G, Darius H, Eckert S, Gohlke-Bärwolf C, Gysan D, et al. Journal article Recommendations of the project group prevention of the German Cardiac Society (DGK) on risk-adjusted prevention of cardiovascular diseases*Part 4: Platelet function inhibitors, hormone replacement therapy, behavioural and psychosocial risk factors Empfehlungen der Projektgruppe Prävention der DGK zur risikoadjustierten Prävention von Herz- und Kreislauferkrankungen Teil 4: Thrombozytenfunktionshemmer, Hormonersatztherapie, Verhaltensänderung und psychosoziale Risikofaktoren (2013) Gohlke H, Albus C, Bönner G, Darius H, Eckert S, Gohlke-Bärwolf C, Gysan D, et al. Journal article Towards clinical evidence in particle therapy: ENLIGHT, PARTNER, ULICE and beyond (2013) Combs SE, Djosanjh M, Poetter R, Orrechia R, Haberer T, Durante M, Fossati P, et al. Journal article WE‐G‐500‐06: Offline PET/CT Imaging of Scanned Proton and Carbon Ion Beams: Initial Clinical Experience for Different Tumour Sites (2013) Parodi K, Bauer J, Kurz C, Unholtz D, Sommerer F, Frey K, Haberer T, et al. Journal article Body mass index and the prevalence, severity, and risk of coronary artery disease: An international multicentre study of 13 874 patients (2013) Labounty TM, Gomez MJ, Achenbach S, Al-Mallah M, Berman DS, Budoff MJ, Cademartiri F, et al. Journal article